Introduction Our mission

Company introduction Location The team Technology Skill

Coronary and heart disease statistics - U.S.A.  About 600,000 people die of heart disease in the United States  Heart disease is the leading cause of death for both men and women.  Coronary heart disease is the most common type of heart disease, killing nearly 380,000 people annually.  Every year about 720,000 Americans have a heart attack.  Coronary heart disease alone costs the United States $108.9 billion each year. Source: Center of Disease Control and Prevention

Prevention – with the aid of genetics  Genetic screening can help us map our health  Pay attention to our health and take necessary steps before symptoms appear First step Second step

Genetics – the code in our genes In general, genes determine the color of our hair, of our eyes, and our height is also controlled by the genes we inherited from our ancestors. Specifically, our genes also determine if we were inclined to heart diseases, high blood pressure or different types of cancer.

Hidden risks – an example Incline to a disease is not detected by normal medical examination or lab screening or x-ray, ultrasound and computer tomography. Only genetic testing can reveal such conditions! Heart disease Bone disorder Bowel dysfunction John (45 years old)

Procedure of genetic testing  Non-invasive  Cell samples taken from the mouth  Self-sampling is also possible  Written report within 3 days  Genetic consultancy on demand

Offered screenings  Sport  Childbirth  Heart- and Vascular  Cancer  Osteoporosis  Dietary  Antioxidant Gene mapping

Benefits of genetic screening  a multitude of examinations can be performed from a single sample  sampling is painless and quick, can performed by the patient himself  samples can be delivered to our center by mail.  world class technology  maximum data security and privacy.

Our complex offer Beside genetic screening we offer the following complex services in our center all performed within fifteen minutes of genetic sampling. Genetic screen Blood and urine screen Physical examination Imaging process Personalized process one center, rapid screen, rapid process Time and cost effected

In-house medication Offering personalized solutions to our customers is our highest goal. In certain cases the symptoms can be relieved by medication produced in-house with our unique world-class technology. These medications are exceptionally effective in the cases of  prostate diseases  joint-dysfunction  Lyme-disease

Future plans Our plans for the future include  International introduction of our medical protocol  Entry of international markets with our world-class medications manufactured with our unique production technology  Development of further world-class products  Broadening the scope of our genetic screening  Taking social responsibility

Needs In order to reach our goals we have to enter a joint venture with our new partners and we have to establish new centers in respective countries. To continue our genetic research and further develop our world-class products and broaden the palette, we require an investment of at least 5 million euros.

Summary  GenePointPlus – private company, offering a wide range of genetic screening  Genetic screening is able to detect disease incline aiding in prevention  Painless, non-invasive sampling, rapid results  Maximum data-security and privacy  In-house produced medication manufactured using unique world- class technology  Ongoing genetic research  Plans of international market entry

Thank you for your attention!